华宝医药生物混合C(019029) - 基金对比
最后更新于：2026-04-24
非全收益率指数点位的计算不包含分红再投入，所以理论上指数基金的分红再投入收益率高于其对应的指数点位涨幅。
加载中......
| 日期 | 华宝医药生物混合C - 相对起始点分红再投入收益率 | 沪深300 - 相对起始点收益率 |
|---|---|---|
| 2026-04-24 | 29.92% | 31.61% |
| 2026-04-23 | 29.31% | 32.08% |
| 2026-04-22 | 32.90% | 32.44% |
| 2026-04-21 | 31.73% | 31.57% |
| 2026-04-20 | 33.63% | 31.28% |
| 2026-04-17 | 34.88% | 30.49% |
| 2026-04-16 | 37.38% | 30.70% |
| 2026-04-15 | 38.23% | 29.29% |
| 2026-04-14 | 33.31% | 29.73% |
| 2026-04-13 | 33.99% | 28.21% |
| 2026-04-10 | 33.06% | 27.94% |
| 2026-04-09 | 33.02% | 26.00% |
| 2026-04-08 | 35.93% | 26.81% |
| 2026-04-07 | 35.37% | 22.54% |
| 2026-04-03 | 36.74% | 22.54% |
| 2026-04-02 | 38.47% | 23.59% |
| 2026-04-01 | 36.58% | 24.89% |
| 2026-03-31 | 27.01% | 22.80% |
| 2026-03-30 | 28.66% | 23.95% |
| 2026-03-27 | 27.78% | 24.25% |
| 2026-03-26 | 19.62% | 23.56% |
| 2026-03-25 | 20.75% | 25.21% |
| 2026-03-24 | 20.06% | 23.48% |
| 2026-03-23 | 15.91% | 21.91% |
| 2026-03-20 | 20.67% | 26.02% |
| 2026-03-19 | 22.57% | 26.47% |
| 2026-03-18 | 24.34% | 28.54% |
| 2026-03-17 | 22.61% | 27.97% |
| 2026-03-16 | 20.35% | 28.91% |
| 2026-03-13 | 18.05% | 28.84% |
| 2026-03-12 | 19.62% | 29.35% |
| 2026-03-11 | 22.57% | 29.82% |
| 2026-03-10 | 24.67% | 29.00% |
| 2026-03-09 | 17.60% | 27.36% |
| 2026-03-06 | 19.54% | 28.60% |
| 2026-03-05 | 14.45% | 28.25% |
| 2026-03-04 | 12.35% | 27.01% |
| 2026-03-03 | 13.93% | 28.48% |
| 2026-03-02 | 17.32% | 30.49% |
| 2026-02-27 | 19.66% | 29.99% |
| 2026-02-26 | 19.82% | 30.44% |
| 2026-02-25 | 22.69% | 30.68% |
| 2026-02-24 | 22.65% | 29.90% |
| 2026-02-13 | 23.54% | 28.60% |
| 2026-02-12 | 25.15% | 30.23% |
| 2026-02-11 | 26.24% | 30.08% |
| 2026-02-10 | 26.77% | 30.36% |
| 2026-02-09 | 23.66% | 30.22% |
| 2026-02-06 | 22.77% | 28.14% |
| 2026-02-05 | 23.21% | 28.88% |